Aprinoia Therapeutics (Aprinoia Therapeutics) Price-to-Free-Cash-Flow : N/A (As of Apr. 28, 2024)

View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Price-to-Free-Cash-Flow?

As of today (2024-04-28), Aprinoia Therapeutics's share price is $0.00. Aprinoia Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.51. Hence, Aprinoia Therapeutics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Aprinoia Therapeutics's Price-to-Free-Cash-Flow or its related term are showing as below:

APRI's Price-to-Free-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 30.52
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Aprinoia Therapeutics's Free Cash Flow per Share for the six months ended in Jun. 2023 was $-0.20. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.51.

Aprinoia Therapeutics Price-to-Free-Cash-Flow Historical Data

The historical data trend for Aprinoia Therapeutics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Price-to-Free-Cash-Flow Chart

Aprinoia Therapeutics Annual Data

Trend

Dec21

Dec22

Price-to-Free-Cash-Flow

Aprinoia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23
Price-to-Free-Cash-Flow	-	-	-	-

Competitive Comparison of Aprinoia Therapeutics's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Aprinoia Therapeutics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprinoia Therapeutics's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Price-to-Free-Cash-Flow falls into.

Aprinoia Therapeutics Price-to-Free-Cash-Flow Calculation

Aprinoia Therapeutics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	0.00	/	-0.508
	=	N/A

Aprinoia Therapeutics's Share Price of today is $0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aprinoia Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.51.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Aprinoia Therapeutics (NAS:APRI) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Aprinoia Therapeutics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines